Back
XTL Biopharmaceuticals Stock Price Chart
![](/images/offers/ims/large/offer5.jpg)
The Next Nvidia?
Go here now for this breaking story.
Sell
37
XTLB
XTL Biopharmaceuticals
Last Price:
2.20
Seasonality Move:
0.88%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer3.jpg)
Elon's New AI Device is About to Shock the World
Click here to see the details because a lot of people could get rich from this new invention.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing selling pressure, which indicates risk of future bearish movement.
XTL Biopharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.25 | Sell |
20-day SMA: | 2.38 | Sell |
50-day SMA: | 2.5 | Sell |
200-day SMA: | 1.48 | Buy |
8-day EMA: | 2.27 | Sell |
20-day EMA: | 2.35 | Sell |
50-day EMA: | 2.36 | Sell |
200-day EMA: | 1.75 | Buy |
XTL Biopharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 43.87 | Sell |
Chaikin Money Flow: | -2083 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.22 - 2.66) | Sell |
Bollinger Bands (100): | (1.19 - 2.85) | Buy |
XTL Biopharmaceuticals Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for XTL Biopharmaceuticals Stock
Is XTL Biopharmaceuticals Stock a Buy?
- XTL Biopharmaceuticals share price is 2.22 while XTLB 8-day simple moving average is 2.25, which is a Sell signal.
- The stock price of XTLB is 2.22 while XTL Biopharmaceuticals 20-day SMA is 2.38, which makes it a Sell.
- XTL Biopharmaceuticals 50-day simple moving average is 2.50 while XTLB share price is 2.22, making it a Sell technically.
- XTLB stock price is 2.22 and XTL Biopharmaceuticals 200-day simple moving average is 1.48, creating a Buy signal.
XTLB Technical Analysis vs Fundamental Analysis
Sell
37
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy or a Sell?
-
XTL Biopharmaceuticals stock is rated a Sell
The current XTL Biopharmaceuticals [XTLB] share price is $2.22. The Score for XTLB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
XTL Biopharmaceuticals Stock Info
Market Cap:
12.1M
Price in USD:
2.22
Share Volume:
2.08K
XTL Biopharmaceuticals 52-Week Range
52-Week High:
4.99
52-Week Low:
0.75
Sell
37
XTL Biopharmaceuticals (XTLB)
is a Sell
XTL Biopharmaceuticals Share Price Forecast
-
What is the XTL Biopharmaceuticals stock price today?
The XTL Biopharmaceuticals stock price is 2.22 USD today. -
Will XTLB stock go up or go down?
XTL Biopharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is XTL Biopharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, XTL Biopharmaceuticals is overvalued.
Is XTL Biopharmaceuticals Stock a Buy?
- XTL Biopharmaceuticals share price is 2.22 while XTLB 8-day exponential moving average is 2.27, which is a Sell signal.
- The stock price of XTLB is 2.22 while XTL Biopharmaceuticals 20-day EMA is 2.35, which makes it a Sell.
- XTL Biopharmaceuticals 50-day exponential moving average is 2.36 while XTLB share price is 2.22, making it a Sell technically.
- XTLB stock price is 2.22 and XTL Biopharmaceuticals 200-day simple moving average is 1.75, creating a Buy signal.
Technical Analysis of XTL Biopharmaceuticals
Should I short XTL Biopharmaceuticals stock?
- XTLB Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting XTL Biopharmaceuticals is a Sell
- XTL Biopharmaceuticals Relative Strength Index (RSI) is 43.87, which suggest XTL Biopharmaceuticals is oversold
- The Bollinger Bands (25) for XTL Biopharmaceuticals is (2.22 - 2.66), which suggest XTL Biopharmaceuticals is a Buy
- The Bollinger Bands (100) for XTL Biopharmaceuticals is (1.19 - 2.85), which suggest XTL Biopharmaceuticals is a Buy
* XTL Biopharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.